A double-blind, randomised, crossover trial of two botulinum toxin type a in patients with spasticity.

A double-blind, randomised, crossover trial of two botulinum toxin type a in patients with spasticity.

<h4>Background</h4>Botulinum toxin type A (btxA) is one of the main treatment choices for patients with spasticity. Prosigne® a new released botulinum toxin serotype A may have the same effectiveness as Botox® in focal dystonia. However, there are no randomized clinical trials comparing...

Full description

Saved in:
Bibliographic Details
Main Authors: Fábio Coelho Guarany, Paulo Dornelles Picon, Nicole Ruas Guarany, Antonio Cardoso dos Santos, Bianca Paula Mentz Chiella, Carolina Rocha Barone, Lúcia Costa Cabral Fendt, Pedro Schestatsky
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2013-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0056479&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0056479&type=printable

Similar Items